Related references
Note: Only part of the references are listed.Molecular heterogeneity of inflammatory breast cancer: A hyperproliferative phenotype
Dang M. Nguyen et al.
CLINICAL CANCER RESEARCH (2006)
Functions of CXCL12 and CXCR4 in breast cancer
Kathryn E. Luker et al.
CANCER LETTERS (2006)
Goals of treatment for patients with metastatic breast cancer
I Smith
SEMINARS IN ONCOLOGY (2006)
Nuclear factor-kappa B signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappa B DNA-binding
Steven J. Van Laere et al.
CLINICAL CANCER RESEARCH (2006)
A new I kappa B kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition
A Tanaka et al.
CANCER RESEARCH (2006)
Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis
S Van Laere et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute
KW Hance et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Update on inflammatory breast cancer
F Lerebours et al.
BREAST CANCER RESEARCH (2005)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
MA Huber et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
NF-KB activation in human breast cancer specimens and its role in cell proliferation and apoptosis
DK Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy
F Bertucci et al.
CANCER RESEARCH (2004)
Molecular profiling of inflammatory breast cancer:: Identification of a poor-prognosis gene expression signature
I Bièche et al.
CLINICAL CANCER RESEARCH (2004)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: Distinct clinicopathologic entities?
WF Anderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
NF-κB in mammary gland development and breast cancer
YX Cao et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2003)
Update on the management of inflammatory breast cancer
M Cristofanilli et al.
ONCOLOGIST (2003)
Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer
E Turpin et al.
ONCOGENE (2002)
Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer
C Costa et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
NF-κB in cancer:: From innocent bystander to major culprit
M Karin et al.
NATURE REVIEWS CANCER (2002)
GeneANOVA - gene expression analysis of variance
G Didier et al.
BIOINFORMATICS (2002)
Selective activation of NF-κB subunits in human breast cancer:: potential roles for NF-κB2/p52 and for Bcl-3
PC Cogswell et al.
ONCOGENE (2000)
Share Paper
